longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Abcellera Biologics

ABCL

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -22.46, below the reasonable range, cheaper than 91.71% of the time in the past 5 years, and the industry ranks 49/59, the industry Median -1.55.

-22.46xP/E
$11.41Stock price
$-0.51Earnings per share
-22.46xP/E
Stock price$11.41Earnings per share$-0.51

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-5.83x
Typical range
-10.57x–14.34x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-332.86x--$45.87B
CRLUSCharles River Laboratorie
-54.63x228.46%$13.03B
TEMUSTempus AI
-48.55x1.23%$12.35B
AVTRUSAvantor
-18.07x142.83%$10.44B
TXGUS10X Genomics
-129.02x105.18%$9.69B
BRKRUSBruker
-79.46x7.71%$8.49B
ADPTUSAdaptive Biotechnologies
-66.68x39.66%$4.26B
ABCLUSAbcellera Biologics
-22.46x34.69%$3.70B
ALMRUSAlamar Biosciences
-40.17x80.55%$2.00B
FTREUSFortrea
-22.02x93.77%$1.88B
MRVIUSMaravai LifeSciences
-23.09x65.83%$1.79B
PSNLUSPersonalis
-16.04x20.05%$1.72B
AZTAUSAzenta
-11.77x180.77%$1.45B
CYRXUSCryoport
-18.20x156.25%$826.09M
CTKBUSCytek Biosciences
-7.89x33.98%$635.62M
OABIUSOmniAb
-14.29x35.96%$632.45M
EVOUSEvotec SE
-2.53x390.22%$578.99M
DNAUSGinkgo Bioworks
-1.62x35.20%$470.71M
PACBUSPacific Biosc California
-3.17x75.82%$416.51M
TKNOUSAlpha Teknova
-22.09x4.69%$370.45M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.